ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

KTRA Kintara Therapeutics Inc

0.155
0.007 (4.73%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Kintara Therapeutics Inc KTRA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.007 4.73% 0.155 18:59:15
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.1472 0.145 0.1617 0.1572 0.148
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
05/4/202412:09PRNUSKuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to..
03/4/202406:00PRNUSKintara Therapeutics and TuHURA Biosciences Enter into..
27/3/202408:00PRNUSKintara Therapeutics Announces Expansion of REM-001 Clinical..
27/2/202405:59EDGAR2Form 8-K - Current report
26/2/202406:00EDGAR2Form 8-K - Current report
22/2/202406:00EDGAR2Form 8-K - Current report
14/2/202415:07PRNUSKintara Therapeutics Announces Fiscal 2024 Second Quarter..
12/2/202408:05EDGAR2Form 8-K - Current report
12/2/202408:00PRNUSKintara Therapeutics Announces Initiation of REM-001..
18/12/202315:10EDGAR2Form 8-K - Current report
18/12/202315:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/12/202315:15EDGAR2Form 8-K - Current report
07/12/202308:10EDGAR2Form 8-K - Current report
07/12/202308:00PRNUSKintara Therapeutics Announces Review of Strategic..
05/12/202308:10EDGAR2Form 8-K - Current report
05/12/202308:00PRNUSKintara Therapeutics Granted Extension by Nasdaq to Regain..
21/11/202306:55EDGAR2Form 8-K - Current report
13/11/202315:15EDGAR2Form 8-K - Current report
13/11/202315:10PRNUSKintara Therapeutics Announces Fiscal 2024 First Quarter..
13/11/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202307:10EDGAR2Form 8-K - Current report
31/10/202307:00PRNUSKintara Therapeutics Announces Preliminary Topline Results..
27/10/202315:05EDGAR2Form S-1/A - General form for registration of securities..
24/10/202315:43EDGAR2Form S-1/A - General form for registration of securities..
10/10/202315:06EDGAR2Form 8-K - Current report
04/10/202315:35EDGAR2Form S-1 - General form for registration of securities under..
26/9/202315:09EDGAR2Form 8-K - Current report
21/9/202308:35GLOBEDawson James Securities Announces October Date for 8th..
19/9/202315:20EDGAR2Form 8-K - Current report
19/9/202315:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/9/202315:31EDGAR2Form 8-K - Current report
18/9/202315:25EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11/9/202315:06EDGAR2Form DEF 14A - Other definitive proxy statements
01/9/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/9/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/9/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/9/202315:05EDGAR2Form PRE 14A - Other preliminary proxy statements
30/6/202316:11EDGAR2Form 8-K - Current report

Su Consulta Reciente

Delayed Upgrade Clock